Letter to the Editor

Detalles Bibliográficos
Autores principales: Deltour, Nicolas, Coste, Maylis, Tupinon-Mathieu, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2012
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437491/
https://www.ncbi.nlm.nih.gov/pubmed/22517617
http://dx.doi.org/10.1002/pds.3283
_version_ 1782242796102483968
author Deltour, Nicolas
Coste, Maylis
Tupinon-Mathieu, Isabelle
author_facet Deltour, Nicolas
Coste, Maylis
Tupinon-Mathieu, Isabelle
author_sort Deltour, Nicolas
collection PubMed
description
format Online
Article
Text
id pubmed-3437491
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-34374912012-09-10 Letter to the Editor Deltour, Nicolas Coste, Maylis Tupinon-Mathieu, Isabelle Pharmacoepidemiol Drug Saf Letters to the Editor John Wiley & Sons, Ltd 2012-06 2012-04-19 /pmc/articles/PMC3437491/ /pubmed/22517617 http://dx.doi.org/10.1002/pds.3283 Text en Copyright © 2012 John Wiley & Sons, Ltd. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Letters to the Editor
Deltour, Nicolas
Coste, Maylis
Tupinon-Mathieu, Isabelle
Letter to the Editor
title Letter to the Editor
title_full Letter to the Editor
title_fullStr Letter to the Editor
title_full_unstemmed Letter to the Editor
title_short Letter to the Editor
title_sort letter to the editor
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437491/
https://www.ncbi.nlm.nih.gov/pubmed/22517617
http://dx.doi.org/10.1002/pds.3283
work_keys_str_mv AT deltournicolas lettertotheeditor
AT costemaylis lettertotheeditor
AT tupinonmathieuisabelle lettertotheeditor

Ejemplares similares